Correlation Between Walker Dunlop and Protara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Protara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Protara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and Protara Therapeutics, you can compare the effects of market volatilities on Walker Dunlop and Protara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Protara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Protara Therapeutics.
Diversification Opportunities for Walker Dunlop and Protara Therapeutics
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Walker and Protara is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Protara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protara Therapeutics and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Protara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protara Therapeutics has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Protara Therapeutics go up and down completely randomly.
Pair Corralation between Walker Dunlop and Protara Therapeutics
Allowing for the 90-day total investment horizon Walker Dunlop is expected to generate 2.36 times less return on investment than Protara Therapeutics. But when comparing it to its historical volatility, Walker Dunlop is 2.53 times less risky than Protara Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Protara Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 137.00 in Protara Therapeutics on September 1, 2024 and sell it today you would earn a total of 164.00 from holding Protara Therapeutics or generate 119.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Walker Dunlop vs. Protara Therapeutics
Performance |
| Timeline |
| Walker Dunlop |
| Protara Therapeutics |
Walker Dunlop and Protara Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Walker Dunlop and Protara Therapeutics
The main advantage of trading using opposite Walker Dunlop and Protara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Protara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protara Therapeutics will offset losses from the drop in Protara Therapeutics' long position.| Walker Dunlop vs. Mr Cooper Group | Walker Dunlop vs. Velocity Financial Llc | Walker Dunlop vs. Security National Financial | Walker Dunlop vs. Encore Capital Group |
| Protara Therapeutics vs. Tff Pharmaceuticals | Protara Therapeutics vs. Eliem Therapeutics | Protara Therapeutics vs. Inhibrx | Protara Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |